Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Life

Offbeat Israel: The Jewish State on Happy Pills?

Israelis may have a reputation for being grouchy; but, statistically speaking, Israelis — including Arab Israelis — are overwhelmingly in a good mood. Or so say pollsters from Tel Aviv University, who conduct monthly surveys to gauge public opinion.

Among the Jewish respondents, 80% of people surveyed defined their personal mood as “very good” or “moderately good.” It seems that those who were infuriated by the outcome of the election have bounced back mood-wise. There was little difference in mood between voters for different parties — with 75% or more of the voters for all the parties defining their mood as well as the national mood as “very good” or “moderately good.”

The unhappy lot, relatively speaking, are Ashkenazi Haredim. Among voters for United Torah Judaism — who generally come from this demographic — only half of people surveyed said their mood was “very good” or “moderately good.” These respondents projected their glum outlook on the rest of the country: Only a quarter of them judged the public to be in one of these two frames of mind.

Some 90% of the Jewish public rated the state’s achievements since its establishment as “very good” or “moderately good.” Expectations about the future are also positive: 81% were “very optimistic” or “moderately optimistic” about the future of the state of Israel. And Jewish Israelis are set to stay put: 81% of the Jewish interviewees said that if given the choice to live in Israel or a different country, they would choose to continue to live in Israel.

Among Arab respondents — all of them Israeli citizens — two-thirds viewed the achievements of the state as “very good” or “moderately good.” One in two defined their mood as “very good,” and a similar ratio said the same of the national mood. Two-thirds of the Arab interviewees were optimistic about the country’s future and an absolute majority (94%) wanted to continue living in Israel.

Could the results have anything to do with how “trendy” the antidepressant Cipralex has become among residents in the Jewish state? According to an article in Haaretz, the antidepressant has seen a recent uptick in sales — with some 40,000 prescriptions being filled each month in Israel.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning journalism this Passover.

In this age of misinformation, our work is needed like never before. We report on the news that matters most to American Jews, driven by truth, not ideology.

At a time when newsrooms are closing or cutting back, the Forward has removed its paywall. That means for the first time in our 126-year history, Forward journalism is free to everyone, everywhere. With an ongoing war, rising antisemitism, and a flood of disinformation that may affect the upcoming election, we believe that free and open access to Jewish journalism is imperative.

Readers like you make it all possible. Right now, we’re in the middle of our Passover Pledge Drive and we still need 300 people to step up and make a gift to sustain our trustworthy, independent journalism.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Only 300 more gifts needed by April 30

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.